Analyses support Ohtuvayre® (ensifentrine) as a first-in-class selective dualinhibitor of PDE3 and PDE4 for a broad COPD ...

Request To Download Free Sample of This Strategic Report@ COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of ...

In Singapore, Dupixent is the first biologic medicine approved to treat these COPD patients. The prevalence of COPD is estimated to be around 6% of the general population [1], and it ranks as a ...

The acquisition of Aluna (also known as Knox Medical Diagnostics, Inc.), a leading U.S.-based company specializing in ...

Aspergillus is a fungus that can lead to life threatening infections of the lungs and blood stream called aspergillosis, ...

Increasing Burden of Organ Failure Driving Demand Organ failure remains a critical healthcare challenge worldwide, with conditions such as end-stage renal disease (ESRD), liver cirrhosis, heart ...

A recent study unravels a centuries-old mystery surrounding a mummified clergyman in Austria. Researchers from Ludwig ...

The U.S. Food and Drug Administration (FDA) approved Kamada's application to manufacture CYTOGAM in May 2023. During the year ...

The global breath analyzer market Key growth drivers include stringent drunk-driving regulations, technological advancements, and increasing adoption across healthcare, law enforcement, and workplace ...

Blood type’s influence extends far beyond compatibility for blood donations, affecting the body through multiple biological ...